Cointime

Nyxoah

company

About

Nyxoah is a medical device company focused on the development and commercialization of a hypoglossal nerve stimulation (HGNS) therapy.

  • 51 - 100

Highlights

Total Funding Amount
€8M
Funding Rounds
1
Investors
1

Details

Last Funding Type
Series A
Last Funding Money Raised
€8M
Industries
Health Care,Medical,Medical Device,Neuroscience
Founded date
Jan 1, 2009
Number Of Employee
51 - 100
Operating Status
Active

Nyxoah is a health-technology company focused on the development and commercialization of innovative solutions and services to treat sleep disordered breathing conditions. Nyxoah's lead solution platform is based on the Genio® system, a validated, user-centered, next generation neurostimulation therapy for OSA, the world's most common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
€8M
Nyxoah has raised a total of €8M in funding over 2 rounds. Their latest funding was raised on May 27, 2014 from a Series A round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
May 27, 2014 Series A €8M 1 Viralety Ventures — Detail

Investors

Number of Lead Investors
Number of Investors
1
1
Nyxoah is funded by 1 investors. Viralety Ventures are the most recent investors.
Investor Name Lead Investor Funding Round
Viralety Ventures Yes Series A
Cointime
Content
Company